Protagonist Therapeutics (PGF) Q3 2026 Earnings Report

1 Followers

DE:PGF Q3 2026 EPS Results

Actual EPS: ―
Consensus EPS: EUR 2.23
Beat/Miss: ―
One Year Ago EPS: -EUR 0.55

DE:PGF Q3 2026 Revenue Results

Actual Revenue: ―
Expected Revenue: EUR 211.90M
Beat/Miss: ―
YoY Revenue Growth: ―

Earnings Announcement Details

Quarter: Q3 2026
Date: 11/05/2026
Time: TBA
Conference Call: Thursday, November 5, 2026

DE:PGF Upcoming Earnings

Protagonist Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:PGF Earnings History

DE:PGF earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 02, 2027	2026 (Q4)	―-	-0.61	―	―
Nov 05, 2026	2026 (Q3)	2.23-	-0.55	―
Aug 05, 2026	2026 (Q2)	1.972.03	-0.49	516.36% (+2.52)
May 05, 2026	2026 (Q1)	-0.410.04	-0.17	126.32% (+0.21)
Feb 25, 2026	2025 (Q4)	-0.50-0.61	1.76	-134.85% (-2.37)
Nov 06, 2025	2025 (Q3)	-0.56-0.55	-0.48	-14.81% (-0.07)
Aug 06, 2025	2025 (Q2)	-0.51-0.49	-0.44	-10.00% (-0.04)
Apr 30, 2025	2025 (Q1)	-0.17-0.16	2.9	-105.67% (-3.06)
Feb 21, 2025	2024 (Q4)	1.021.76	0.39	350.00% (+1.37)
Nov 07, 2024	2024 (Q3)	-0.51-0.48	-0.52	6.90% (+0.04)
Aug 06, 2024	2024 (Q2)	-0.53-0.44	-0.6	26.47% (+0.16)
May 08, 2024	2024 (Q1)	2.992.90	-0.6	586.57% (+3.49)
Feb 27, 2024	2023 (Q4)	0.050.39	-0.61	163.77% (+1.00)
Nov 02, 2023	2023 (Q3)	-0.59-0.52	-0.57	9.38% (+0.05)
Aug 03, 2023	2023 (Q2)	-0.59-0.60	-0.75	19.05% (+0.14)
May 04, 2023	2023 (Q1)	-0.65-0.60	-0.38	-55.81% (-0.21)
Mar 15, 2023	2022 (Q4)	-0.59-0.61	-0.68	10.39% (+0.07)
Nov 08, 2022	2022 (Q3)	-0.77-0.57	-0.62	8.57% (+0.05)
Aug 04, 2022	2022 (Q2)	-0.83-0.75	-0.61	-21.74% (-0.13)
May 04, 2022	2022 (Q1)	-0.48-0.38	-0.48	20.37% (+0.10)
Feb 28, 2022	2021 (Q4)	-0.69-0.68	-0.43	-60.42% (-0.26)
Nov 03, 2021	2021 (Q3)	-0.60-0.62	-0.19	-233.33% (-0.44)
Aug 04, 2021	2021 (Q2)	-0.48-0.61	-0.52	-16.95% (-0.09)
May 04, 2021	2021 (Q1)	―-0.48	-0.64	25.00% (+0.16)
Mar 10, 2021	2020 (Q4)	―-0.43	-0.56	23.81% (+0.13)
Nov 04, 2020	2020 (Q3)	―-0.19	-0.54	65.57% (+0.36)
Aug 06, 2020	2020 (Q2)	―-0.52	-1.05	50.00% (+0.52)
May 07, 2020	2020 (Q1)	―-0.64	-0.52	-24.14% (-0.12)
Mar 10, 2020	2019 (Q4)	―-0.56	-0.51	-10.53% (-0.05)
Nov 06, 2019	2019 (Q3)	―-0.54	-0.34	-60.53% (-0.20)
Aug 07, 2019	2019 (Q2)	―-1.05	-0.36	-187.80% (-0.68)
May 08, 2019	2019 (Q1)	―-0.52	-0.32	-61.11% (-0.20)
Mar 12, 2019	2018 (Q4)	―-0.51	-0.13	-280.00% (-0.37)
Nov 06, 2018	2018 (Q3)	―-0.34	-0.26	-31.03% (-0.08)
Aug 07, 2018	2018 (Q2)	―-0.36	-0.79	53.93% (+0.43)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Protagonist Therapeutics earnings date